This IDC study is the second of a three-part life science R&D IDC MarketScape series focused on IT outsourcing. With a specific focus on life science R&D ITO, this document seeks to compare major IT service providers with each other, based on operational, business, and market-centric criteria that should be important to life science companies when considering the selection of an external service provider to take over noncore IT activities. IDC MarketScape assessment of IT outsourcing in life science R&D was previously performed in 2011, 2013, and 2015.
Alan Louie, research director of IDC Health Insights' Life Science R&D Technology, and Strategy research, noted, "ITO remains a key element in delivering IT infrastructure support and evolution in the life sciences today. Leading life science companies fully rely on external IT service provider partners to help them grow and transform while concurrently delivering ongoing operational excellence. While AI and robotic process automation will likely change the IT services space over the longer term, growth in ITO will be needed to accommodate that change. As a result, IDC expects that IT outsourcing will continue to grow at high single-digit rates over the near term as industry transformation continues."
Navitas Life Sciences Limited, Indegene Lifesystems Pvt Ltd., HCL, Wipro Limited, Tata Consultancy Services Limited, Cognizant Technology Solutions Corporation, Tech Mahindra Limited, NTT, Accenture plc, Infosys Limited, DXC Technology Co.
List of Tables
List of Figures
When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.